ANG Lifesciences India Limited (ANG.BO)
INR 45.93
(-1.12%)
INR 45.93
(-1.12%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | 1.46 Billion | 2.19 Billion | 3.54 Billion | 1.53 Billion | 1.26 Billion | 1.21 Billion |
| Cost of Revenue | 1.22 Billion | 1.5 Billion | 2.27 Billion | 1.03 Billion | 889.69 Million | 878.4 Million |
| Gross Profit | 232.73 Million | 691.88 Million | 1.26 Billion | 499.42 Million | 378.02 Million | 338.23 Million |
| Operating Expenses | 219.92 Million | 623.79 Million | 625.17 Million | 357.93 Million | 258.2 Million | 216.04 Million |
| Selling, General and Administrative Expenses | 196.85 Million | 49.47 Million | 83.9 Million | 52.96 Million | 48.16 Million | 31.59 Million |
| Research and Development Expenses | - | - | 2.5 Million | - | - | - |
| Other Expenses | - | 82.33 Million | 6.1 Million | 3.53 Million | 1.01 Million | 773.83 Thousand |
| Cost and Expenses | 1.44 Billion | 2.12 Billion | 2.9 Billion | 1.39 Billion | 1.14 Billion | 1.09 Billion |
| Operating Income | 12.8 Million | 63.08 Million | 624.75 Million | 130.89 Million | 117.35 Million | 108.37 Million |
| Interest Expense | 109.57 Million | 111.92 Million | 82.79 Million | 30.73 Million | 28.98 Million | 23.74 Million |
| Income Tax Expense | -5.7 Million | 28.87 Million | 131.84 Million | 31.11 Million | 23.1 Million | 24.59 Million |
| Earnings before Tax | -107.13 Million | 26.25 Million | 535 Million | 101.39 Million | 84.06 Million | 81.08 Million |
| Net Income | -101.43 Million | -2.62 Million | 403.16 Million | 70.27 Million | 60.95 Million | 56.48 Million |
| Earnings Per Share Basic | -7.77 | -0.20 | 31.11 | 5.42 | 4.70 | 4.36 |
| Earnings Per Share Diluted | -7.77 | -0.20 | 31.11 | 5.42 | 4.70 | 4.36 |
| Weighted Average Shares Outstanding | 13.05 Million | 12.99 Million | 12.95 Million | 12.95 Million | 12.95 Million | 12.95 Million |
| Weighted Average Shares Outstanding (Diluted) | 13.05 Million | 12.99 Million | 12.95 Million | 12.95 Million | 12.95 Million | 12.95 Million |
| Gross Margin | 0.16 | 0.31 | 0.36 | 0.32 | 0.30 | 0.28 |
| EBIT Margin | 0.06 | 0.11 | 0.20 | 0.10 | 0.10 | 0.11 |
| Profit Margin | -0.07 | -0.00 | 0.11 | 0.05 | 0.05 | 0.05 |
| EBITDA | 90.66 Million | 244.59 Million | 687.97 Million | 139.73 Million | 125.58 Million | 117.21 Million |
| Earnings Before Tax Margin | 0.01 | 0.03 | 0.18 | 0.09 | 0.09 | 0.09 |
| Breakdown | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 |
|---|---|---|---|---|---|---|
| Revenue | 184.1 Million | 1.46 Billion | 378.39 Million | 185.45 Million | 332.61 Million | 564.62 Million |
| Cost of Revenue | 175.66 Million | 1.22 Billion | 312.6 Million | 179.77 Million | 215.19 Million | 369.56 Million |
| Gross Profit | 8.43 Million | 232.73 Million | 65.79 Million | 5.67 Million | 117.42 Million | 195.06 Million |
| Operating Expenses | 41.86 Million | 219.92 Million | 52.69 Million | 43.92 Million | 123.06 Million | 151.47 Million |
| Selling, General and Administrative Expenses | 41.86 Million | - | 52.69 Million | 43.92 Million | 51.37 Million | 71.94 Million |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | 12.84 Million | 6.98 Million | 1.87 Million | -293 Thousand | 2.23 Million | 3.16 Million |
| Cost and Expenses | 217.52 Million | 1.44 Billion | 365.29 Million | 223.7 Million | 338.26 Million | 521.03 Million |
| Operating Income | -33.42 Million | 12.8 Million | 13.1 Million | -38.24 Million | -5.64 Million | 43.59 Million |
| Interest Expense | 20.83 Million | 109.57 Million | 38.39 Million | 25.14 Million | 22.89 Million | 23.14 Million |
| Income Tax Expense | -10.68 Million | -5.7 Million | -4.29 Million | -4.37 Million | -3.13 Million | 6.09 Million |
| Earnings before Tax | -41.41 Million | -107.13 Million | -40.76 Million | -63.68 Million | -26.3 Million | 23.61 Million |
| Net Income | -30.73 Million | -101.43 Million | -36.46 Million | -59.31 Million | -23.17 Million | 17.52 Million |
| Earnings Per Share Basic | -2.35 | - | -2.79 | -4.54 | -1.77 | 1.34 |
| Earnings Per Share Diluted | -2.35 | - | -2.79 | -4.54 | -1.77 | 1.34 |
| Weighted Average Shares Outstanding | 13.05 Million | 13.05 Million | 13.05 Million | 13.05 Million | 13.05 Million | 13.05 Million |
| Weighted Average Shares Outstanding (Diluted) | 13.05 Million | 13.05 Million | 13.05 Million | 13.05 Million | 13.05 Million | 13.05 Million |
| Gross Margin | 0.05 | 0.16 | 0.17 | 0.03 | 0.35 | 0.35 |
| EBIT Margin | -0.09 | - | 0.09 | -0.10 | 0.06 | 0.12 |
| Profit Margin | -0.17 | -0.07 | -0.10 | -0.32 | -0.07 | 0.03 |
| EBITDA | -17.09 Million | - | 33.57 Million | -19.1 Million | 18.81 Million | 68.63 Million |
| Earnings Before Tax Margin | -0.18 | 0.01 | 0.03 | -0.21 | -0.02 | 0.08 |
FMNB
RCOM
CDIX
ARQT
SMR-WT
BSPM